Article
Autologous genome-edited hematopoietic stem cells correct Gaucher disease and establish a platform for clinical translation
2025-08-18
Abstract excerpt
<title>Abstract</title> <p>Gaucher disease type 1 is a lysosomal storage disorder caused by <italic>GBA1</italic> mutations that reduce glucocerebrosidase activity, leading to glycolipid buildup, particularly in macrophages. To develop a curative approach, we established a high-efficiency genome editing platform for human and murine hematopoietic stem-progenitor cells using CRISPR/Cas9, recombinant adeno-associat...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d421e7fa-158e-5eb6-808c-0db24efd0a06
- DOI
- 10.21203/rs.3.rs-7123212/v1
